For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for C-reactive protein (CRP).
JJX
Single (Specified) Analyte Controls (Assayed And Unassayed)
For the quantitative determination of human C-reactive protein (CRP) in serum an
For the quantitative determination of human C-reactive protein (CRP) in serum and plasma by immunoturbidimetric assay.
DCK
C-Reactive Protein, Antigen, Antiserum, And Control
For the quantitative determination of human rheumatoid factor (RF) in serum by i
For the quantitative determination of human rheumatoid factor (RF) in serum by immunoturbidimetric assay.
For the quantitative determination of human albumin in urine by immunoturbidimet
For the quantitative determination of human albumin in urine by immunoturbidimetric assay.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for microalbumin.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for microalbumin.
For the quantitative determination of human cystatin C in serum, EDTA plasma, or
For the quantitative determination of human cystatin C in serum, EDTA plasma, or lithium heparin plasma by immunoturbidimetric assay.
For the quantitative determination of human ferritin in serum and plasma by immu
For the quantitative determination of human ferritin in serum and plasma by immunoturbidimetric assay.
For the quantitative determination of human 3rd complement component (Complement
For the quantitative determination of human 3rd complement component (Complement C3) in serum by immunoturbidimetric assay.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for the listed constituents.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for C-reactive protein (CRP).
DCK
C-Reactive Protein, Antigen, Antiserum, And Control
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for the listed constituents.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for the listed constituents.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for hemoglobin A1c.
For the calibration of the K-ASSAY® Alpha-1 AG, Alpha-1 AT, Complement C3, Comle
For the calibration of the K-ASSAY® Alpha-1 AG, Alpha-1 AT, Complement C3, Comlement C4, Haptoglobin, IgA, IgG, IgM, and Transferrin assays.
For the quantitative determination of human streptolysin O (ASO) in serum by imm
For the quantitative determination of human streptolysin O (ASO) in serum by immunoturbidimetric assay.
For the quantitative determination of human apolipoprotein B (Apo B) in serum by
For the quantitative determination of human apolipoprotein B (Apo B) in serum by immunoturbidimetric assay.
For the quantitative determination of human alpha-1 anti-trypsin (Alpha-1 AT) in
For the quantitative determination of human alpha-1 anti-trypsin (Alpha-1 AT) in serum by immunoturbidimetric assay.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for Apolipoprotein AI and B.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for Apolipoprotein AI and B.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for beta-2 microglobulin.
JJX
Single (Specified) Analyte Controls (Assayed And Unassayed)
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for beta-2 microglobulin.
JJX
Single (Specified) Analyte Controls (Assayed And Unassayed)
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for D-Dimer.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for the listed constituents.
For the quantitative determination of human total IgE in serum or plasma by immu
For the quantitative determination of human total IgE in serum or plasma by immunoturbidimetric assay.
For the quantitative determination of human D-dimer in plasma or serum by immuno
For the quantitative determination of human D-dimer in plasma or serum by immunoturbidimetric assay.
For the quantitative determination of human insulin in serum and plasma by immun
For the quantitative determination of human insulin in serum and plasma by immunoturbidimetric assay.
For the quantitative determination of human C-reactive protein (CRP) in serum by
For the quantitative determination of human C-reactive protein (CRP) in serum by immunoturbidimetric assay.
DCK
C-Reactive Protein, Antigen, Antiserum, And Control
For the quantitative determination of human 4th complement component (Complement
For the quantitative determination of human 4th complement component (Complement C4) in serum by immunoturbidimetric assay.
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for beta-2 microglobulin.
JJX
Single (Specified) Analyte Controls (Assayed And Unassayed)
1
K-ASSAY® Beta-2 Microglobulin / Ferritin - Serum / Plasma Control
The Heparin/Platelet Factor 4 Antibody Serum Panel is an assayed control, intend
The Heparin/Platelet Factor 4 Antibody Serum Panel is an assayed control, intended for use as a serum QC control to monitor and evaluate precision and accuracy of the (qualitative) PIFA® Heparin/PF4 Rapid Assay. Included are both confirmed positive and negative control panel members.
The Heparin/Platelet Factor 4 Antibody Serum Panel is an assayed control, intend
The Heparin/Platelet Factor 4 Antibody Serum Panel is an assayed control, intended for use as a serum QC control to monitor and evaluate precision and accuracy of the (qualitative) PIFA® Heparin/PF4 Rapid Assay. Included are both confirmed positive and negative control panel members.
The Xprecia™ System PT Controls; For use with Xprecia System, supplying assayed
The Xprecia™ System PT Controls; For use with Xprecia System, supplying assayed controls for prothrombin time (PT).
The Xprecia Stride™ Coagulation System is intended for use by professional healt
The Xprecia Stride™ Coagulation System is intended for use by professional healthcare providers to provide an INR (InternationalNormalized Ratio) based on a Prothrobin time (PT) response for the monitoring of oral anticoagulation therapy with Warfarin.
A pool of normal citrated human plasma collected from a minimum of 20 donors, bu
A pool of normal citrated human plasma collected from a minimum of 20 donors, buffered with 0.05M HEPES and stabilizers, dispensed and lyophilized. This plasma is used for the quality control of coagulation assays in the normal range, including fibrinogen, coagulation factors II, V, VII, VIII, IX, X XI and XII, ATIII activity, Protein C activity and Protein S activity.
A pool of citrated normal human plasma collected from a minimum of 20 donors, an
A pool of citrated normal human plasma collected from a minimum of 20 donors, and diluted to defined concentrations. Plasma is buffered with 0.05M HEPES and stabilizers, dispensed and lyophilized. This plasma is used for the quality control of coagulation assays in the normal range, including fibrinogen, coagulation factors II, V, VII, VIII, IX, X XI and XII, ATIII activity, Protein C activity and Protein S activity.
A pool of citrated human plasma collected from a minimum of 20 donors that has b
A pool of citrated human plasma collected from a minimum of 20 donors that has been depleted of specific clotting factors. The plasma is buffered with 0.05M HEPES buffer and stabilizers, dispensed and lyophilized. This plasma is used for the quality control of coagulation assays (PT and APTT) in the highly abnormal range.
A pool of citrated human plasma collected from a minimum of 20 donors that has b
A pool of citrated human plasma collected from a minimum of 20 donors that has been depleted of specific clotting factors. The plasma is buffered with 0.05M HEPES buffer and stabilizers, dispensed, and lyophilized. This plasma is used for the quality control of coagulation assays (PT and APTT) in the mid-level abnormal range.
A pool of normal citrated human plasma collected from a minimum of 20 donors, bu
A pool of normal citrated human plasma collected from a minimum of 20 donors, buffered with 0.05M HEPES buffer and stabilizers, dispensed and lyophilized. This plasma is used for the quality control of coagulation assays (PT, APTT and Fibinogen) in the normal range.
Intended for use in the quality control of quantitative coagulation assays, incl
Intended for use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) in the mid-level abnormal range.
Intended for use in the quality control of quantitative coagulation assays, incl
Intended for use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT), in the mid-level abnormal range.
Intended for use in the quality control of quantitative coagulation assays, incl
Intended for use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT), in the mid-level abnormal range.
Intended for use in the quality control of quantitative coagulation assays, incl
Intended for use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT) and Fibrinogen, in the normal range.
Intended for the use in the quality control of quantitative coagulation assays,
Intended for the use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT) and Fibrinogen, in the normal range.